This is a critical time in this case to save Sorrento!

It is my understanding that it would take about $4 million to fund Ovydso, Sorrento’s therapy drug, that is reportedly close to approval in China.

Such an approval could provide the necessary cash flow for Sorrento to exit bankruptcy versus the current liquidation plan set to be executed sometime in 2024.

The “professionals” do not seem interested in funding Ovydso via a small clawback in their fees and yet these same professionals in a recent hearing admitted that this therapy was potentially good for humanity! 

See the following court document:

https://cases.stretto.com/public/x228/12086/PLEADINGS/1208612162380000000012.pdf

GLTAL!

Kimberly